Search Results for: CRISPR
R&D Genome Editing
Re-engineered Bacterial “Syringes” for Programmable Protein Delivery
2023-04-06
Licensing
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Special Cell and Gene Therapy
Developments in Regenerative Medicine: Gene Delivery Tools and Cell Therapy for Parkinson’s Disease
2023-03-08
Ranking & Reports Gene Therapy
Patent Landscape Analysis of Gene Therapy
2023-02-08
M&A CRISPR
Sherlock Biosciences Buys Sense Biodetection to Accelerate CRISPR-Based Handheld Diagnostic Tests
2023-02-02
Licensing JPM
JPM23: Partnerships Take off From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
An Updated View on the “Central Dogma” of Molecular Biology
2023-01-03
R&D Gene Editing
Treating Common Heart Disease with CRISPR-Cas9 Gene Editing
2022-12-27
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-11-30
Interviews BeiGene
Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene
2022-10-05
Funding Oncology
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Special KoreaBio
Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO
2022-08-31
Trials & Approvals Gene Therapy
Gene Repair Therapy: First Patient Dosed With New Treatment for Sickle Cell Disease
2022-08-11
Special BIOplus
BIX 2022 – Opening Doors to Korea’s Biopharmaceutical Industry
2022-07-27
Partnerships Liver Disease
Verve and Vertex Agree to Co-Develop In Vivo Gene Editing Program for Liver Disease
2022-07-21
1 2 3 … 16
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top